Treatment restores the esterase level to the average mean activity of random normal as the patient becomes euthyroid.
There is no evidence in the present investigation that any of the pseudocholinesterase variants modify these conclusions.
Many pathological conditions have been shown to alter serum cholinesterase levels in man. A decrease in serum cholinesterase activity is associated with liver disease (McArdle, 1940) and organophosphorus poisoning (Barnes and Davies, 1951) . Other pathological conditions in which a decrease in activity has been reported are malnutrition (Waterlow, 1950) ; severe anaemia (Scudamore, Vorhaus, and Kark, 1951) ; hyperpyrexia (Antopol, Tuchman, and Schifrin, 1937) ; infectious diseases (Hall and Lucas, 1937) ; cardiac failure, uraemia (McArdle, 1940) ; catatonia (Tod and Jones, 1937) ; and malignancy, particularly of the alimentary tract (Koster and Kisch, 1943 ). An increase in serum cholinesterase level has been reported in obesity (Berry, Cowin, and Davies, 1954) ; nodular goitre (Koster and Kisch, 1943) ; psoriasis (Helmeczy and Nagy, 1954) ; and essential hypertension (Reinfrank and Whetstone, 1958) . A high esterase level was found by chance in a patient known to have a high basal metabolic rate and so it was decided to study esterase levels in thyrotoxicosis and myxoedema.
A series of 60 such cases was investigated and in some patients it has been possible to follow esterase levels during differing treatments. The esterase levels of many of the patients were determined after they had become euthyroid.
METHODS
Pseudocholinesterase activity using acetylcholine as substrate was determined micromanometrically (Callaway, Davies, and Rutland, 1951 
RESULTS
The average esterase levels for both substrates in patients with thyrotoxicosis and myxoedema are shown in Table I . In addition the esterase levels for Staron, 1957) . A good correlation exists between the activities using acetylcholine and benzoylcholine as substrates (Fig. 1) . DISCUSSION A mean increase of activity was observed in esterase levels of patients with thyrotoxicosis when compared with the esterase levels found in a random sample of the population (Table I ). This increase in activity is of the magnitude of 20% and was found for both substrates.
One patient with thyrotoxicosis was found to be an heterozygote phenotype. The esterase levels using acetyl and benzoyl-choline were 107 and 118 units respectively. This phenotype has been shown to average 79 units (S.D. = 23) for 122 individuals using benzoylcholine as substrate (Whittaker, 1964) and 80 units (S.D. = 21) for 37 individuals with acetylcholine as substrate. Neither the atypical nor the fluoride-resistant phenotypes were encountered during this survey.
As soon as the patients became euthyroid the esterase levels were measured by both methods. The results ( In the 12 patients with myxoedema the mean activity for pseudocholinesterase level was about 300% lower than that found in random normals using either substrate. It has not been possible to follow the treatment of these patients until they became euthyroid except in one case when the activity rose from 93 units (acetylcholine) before treatment to 135 units at the time when the patient became euthyroid, illustrating that even when myxoedema is not associated with a subnormal esterase activity, a rise in activity does occur when the patient becomes euthyroid.
Electrophoresis has revealed that 'normal' serum cholinesterase can be classified into two variants, C,5 + and C5-. The variant C5'+ has been shown to have a mean activity of about 30 % higher than those of the C5-individuals, using benzoylcholine as substrate (Harris, Hopkinson, Robson, and Whittaker, 1963) . One of the sera investigated in this instance was of the C5+ type, in a myxoedemic patient. In this case the esterase levels for both substrates were 105 units which is about 33 % higher than the mean activity for the other myxoedemic patients. This patient has yet to become euthyroid.
